Literature DB >> 19889052

Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.

Jonathan L Curry1, Victor G Prieto, Dan M Jones, Franscisco Vega, Madeleine Duvic, A Hafeez Diwan.   

Abstract

Immunodeficiency-related lymphoproliferative disorders (IR-LPD) may occur in the setting of immunosuppressive therapy with methotrexate and TNF-α antagonists. As far as we are aware, this is the first report of an Epstein-Barr virus-associated B-cell lymphoproliferative disorder, secondary to methotrexate therapy in a patient with mycosis fungoides/Sézary syndrome.
Copyright © 2009 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 19889052     DOI: 10.1111/j.1600-0560.2009.01459.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  2 in total

1.  EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.

Authors:  Yasodha Natkunam; John R Goodlad; Amy Chadburn; Daphne de Jong; Dita Gratzinger; John K C Chan; Jonathan Said; Elaine S Jaffe
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

2.  Methotrexate-induced Primary Cutaneous Diffuse Large B-cell Lymphoma in Patients with Erythrodermic Cutaneous T-cell Lymphoma.

Authors:  Jérémie Delaleu; Eve Maubec; Francois Rodrigues; Annie Lévy; Vanessa Szablewski; Lilliane Laroche; Olivier Dereure
Journal:  Acta Derm Venereol       Date:  2020-08-17       Impact factor: 3.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.